Skip to content
DefDex

Federal award

QUIDELORTHO SALES COMPANY, LLC

W81K0221P0078

Contract

Obligated and Ceiling

Obligated (net)
$54,278.01
Ceiling (potential value, not spending)
$54,278.01
Current value
$54,278.01
Gross positive obligations
$197,213.53

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
QUIDELORTHO SALES COMPANY, LLC · ZFXRG96JMJ39
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
QUIDELORTHO SALES COMPANY, LLC · ZFXRG96JMJ39
Awarding agency
Department of War · sub-agency 2100 · office W81K02
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0221P0078
Award type code
B
Actions
13 · May 21, 2021 to Sep 26, 2025
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History13

Award actions
DateFYModAction typeObligationCompany in company totals
Sep 26, 2025FY2025P00012J$0.00
—
Aug 12, 2025FY2025P00011B−$13,605.73
—
Feb 5, 2025FY2025P00010B−$16,787.70
—
Oct 22, 2024FY2025P00009C$33,895.78
—
Aug 22, 2024FY2024P00008B−$67,646.04
—
May 17, 2024FY2024P00007G$0.00
—
Oct 6, 2023FY2024P00006C$54,439.25
—
Mar 27, 2023FY2023P00005G$0.00
—
Oct 20, 2022FY2023P00004C$54,439.25
—
Jul 13, 2022FY2022P00003B−$44,896.05
—
May 24, 2022FY2022P00002G$0.00
—
Oct 18, 2021FY2022P00001C$54,439.25
—
May 21, 2021FY20210—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.